Reciprocal relationship from EVAX graph: Reciprocal relationship from BNTX graph: Reciprocal relationship from EVAX graph: drugs, has become intense. As a result, increasingly high barriers are being…
Reciprocal relationship from MGNX graph: n exclusive option to license worldwide rights to the research program, upon achievement of a pre-defined preclinical milestone. HIV DART Molecules We conduct…
Reciprocal relationship from MRVI graph: Reciprocal relationship from BNTX graph: Reciprocal relationship from MRVI graph: Reciprocal relationship from BNTX graph: Reciprocal relationship from MRVI g…
Reciprocal relationship from MTNB graph: Reciprocal relationship from BNTX graph: Reciprocal relationship from MTNB graph: Reciprocal relationship from BNTX graph: Reciprocal relationship from MTNB g…
Reciprocal relationship from SMMT graph: Reciprocal relationship from BNTX graph: Reciprocal relationship from SMMT graph: Reciprocal relationship from BNTX graph: Reciprocal relationship from SMMT g…
Reciprocal relationship from EVAX graph: ing income in the mid double-digit range. We have initiated a Phase 2 trial, hence this term is no longer relevant. Prior to any out-licensing commercializati…
Reciprocal relationship from MGNX graph: t and future product candidates. Most of the principal materials we use in our manufacturing operations are available from more than one source. However, we o…
Reciprocal relationship from MTNB graph: contractors associated with Chemistry and Manufacturing Controls (CMC), pre-clinical and clinical activities and regulatory operations; ● expenses incurred un…
Reciprocal relationship from SMMT graph: Reciprocal relationship from BNTX graph: Reciprocal relationship from SMMT graph: Reciprocal relationship from BNTX graph: Reciprocal relationship from SMMT g…
BioNTech SE Debt Obligations
Instrument
Description
Confidence
Evidence
BNTX-DEBT
Debt stack $352.2M
90%
Market cache reports total debt of $352.2M.
BioNTech SE Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for BioNTech SE.
BioNTech SE Ownership
Holder
Name
Confidence
Evidence
BNTX-OWNER-T-ROWE-PRICE-INVESTMENT-MANAGEME
T. Rowe Price Investment Management, Inc.
90%
13F overlay lists T. Rowe Price Investment Management, Inc. as top holder; 274 tracked holders.